Ei Increases Capabilities Through New Partnership
Ei, A Pharmaceutical SolutionWorks, recently announced a new partnership with KeraNetics. Ei has begun a $13.2-million expansion within their recently completed 147,000-sq-ft facility in
KeraNetics specializes in the creation of therapeutic medical products utilizing keratins, a class of structural proteins with unique physical, chemical, and biological characteristics designed to promote soft and hard tissue repair and regeneration by providing an environment to support the body’s natural healing process. KeraNetics controls numerous patents for methods of purifying keratin proteins and applications for regenerative medicine and trauma.
“We are excited to announce our new partnership with KeraNetics,” said Michael Kane, CEO, Ei. “We believe KeraNetics recognizes our team as product knowledge experts. A relationship of this magnitude showcases the level of skill and technology-driven innovation that exists in the DNA of Ei. Further, it illustrates the intellectual capital Ei brings to the table and taps into the strong business-to-business relationships we have forged and continue to maintain with our customers. We are not only assisting in the development and manufacturing of exciting new products, but are providing an added value to KeraNetics as a bridge to Ei’s like-minded customers.”
“The relationship with Ei has developed as a result of KeraNetics’ intent to bring these exciting new keratin-based products to market,” addedd Kim Westmoreland, Managing Director, KeraNetics. “We were originally looking at building a facility to manufacture these cutting-edge, keratin products that would have involved years of planning and construction. After meeting the leadership team at Ei and touring their state-of-the-art facility, we realized this partnership would allow us to cut those years out of the equation and create access to these products much more quickly. We could not be more pleased.”
Luke Barnett, Director of Research and Development, KeraNetics, added, “The high level of innovation exhibited in Ei’s current product lines also played a role in their selection. The level of skill and knowledge in their research and development team is a huge asset. We were looking for a long-term relationship with a company that could assist us in not only manufacturing these products, but serve as a partner and ally in looking toward future offerings.”
Ei focuses on Rx pharmaceutical, OTC, therapeutic skin care, and animal health markets. The company provides product development services ranging from formula development, testing, and package development. Ei specializes in regulatory assistance through clinical trial manufacturing, scale-up, and commercial production as well as offering specific development and manufacturing services.
Ei prides itself on not just the cutting-edge science and state-of-the-art manufacturing expertise of its people, but the protection and strengthening of each individual customer’s brand. Continual growth of Ei in their capabilities is illustrated in this new partnership. This corporate acknowledgement of a higher level of skill and care resulted in the re-branding of Ei in 2011 from a traditional contract manufacturing organization to a Pharmaceutical SolutionWorks. Working in tandem to create unique, differential products with their customers, Ei fulfills that promise through the manufacturing and delivery stages. For more information, visit www.eisolutionworks.com.
KeraNetics is the global leader in the development and manufacturing of purified keratin medical products. Headquartered in
Total Page Views: 1280
